Allergies, Sinusitis & Immune Reactions • ICD-10-CM J30.9
Hay fever (allergic rhinitis)
Also known as: Rhinitis - allergic, Allergy, Alrgy, Allergic, Allergies
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM J30.9 • 6 Linked .gov / PubMed Citations
•
Governance: Dr. Marcus Thorne, MD, FACC (NPI #1184629314)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Hay fever (allergic rhinitis) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Allergies, Sinusitis & Immune Reactions practice, Hay fever (allergic rhinitis) (also termed Rhinitis - allergic or Allergy) (ICD-10 J30.9) is stratified through intranasal corticosteroid optimization [Hay fever (allergic rhinitis) J30.9], pairing targeted symptom control with longitudinal Specific IgE Allergen in Hay fever (allergic rhinitis) (J30.9: Panel / Skin) surveillance.
- 2 Real-world patient consensus: Mapped to Allergies, Sinusitis & Immune Reactions under ICD-10-CM J30.9 for Hay fever (allergic rhinitis) clinical workups.
- 3 Typical cash cost range: Differential triage of Hay fever (allergic rhinitis) (J30.9) utilizes intranasal corticosteroid optimization [Hay fever (allergic rhinitis) J30.9].
- 4 Top reported side effects / signs: Longitudinal Hay fever (allergic rhinitis) monitoring tracks Serum Total IgE in Hay fever (allergic rhinitis) (J30.9: & Tryptase (if) toward Tryptase < 11.4 ng/mL (J30.9).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Hay fever (allergic rhinitis)
What Is Hay fever (allergic rhinitis)?
Within Allergies, Sinusitis & Immune Reactions practice, Hay fever (allergic rhinitis) (also termed Rhinitis - allergic or Allergy) (ICD-10 J30.9) is stratified through intranasal corticosteroid optimization [Hay fever (allergic rhinitis) J30.9], pairing targeted symptom control with longitudinal Specific IgE Allergen in Hay fever (allergic rhinitis) (J30.9: Panel / Skin) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
In Hay fever (allergic rhinitis) (J30.9), physiological disruption stems from basophil degranulation releasing in Hay fever (allergic rhinitis) (J30.9: histamine), informing Allergies, Sinusitis & Immune Reactions protocols that track Specific IgE Allergen in Hay fever (allergic rhinitis) (J30.9: Panel / Skin) (Targeted trigger identification (J30.9)).
Common Symptoms & Clinical Signs
- • Presentation of Hay fever (allergic rhinitis) (J30.9): transient raised pruritic in Hay fever (allergic rhinitis) (J30.9: skin wheals)
- • Secondary Hay fever (allergic rhinitis) clinical sign: reproducible mucosal, respiratory, in Hay fever (allergic rhinitis) (J30.9: or GI reactions)
- • Symptom flares in Hay fever (allergic rhinitis) correlating with Serum Total IgE in Hay fever (allergic rhinitis) (J30.9: & Tryptase (if) deviation outside Tryptase < 11.4 ng/mL (J30.9)
- • Functional allergies & sinus impact requiring intranasal corticosteroid optimization [Hay fever (allergic rhinitis) J30.9] evaluation (J30.9)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Hay fever (allergic rhinitis) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J30.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Allergies, Sinusitis & Immune Reactions | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Total IgE in Hay fever (allergic rhinitis) (J30.9: & Tryptase (if) | Tryptase < 11.4 ng/mL (J30.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Specific IgE Allergen in Hay fever (allergic rhinitis) (J30.9: Panel / Skin) | Targeted trigger identification (J30.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Absolute Eosinophil Count [Hay fever (allergic rhinitis) J30.9] | 0 – 300 cells/uL (J30.9) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Hay fever (allergic rhinitis)
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Desloratadine Clarinex • RxCUI 349420 | Histamine-1 Receptor Antagonist | 80% | $0.2553 | $ 9.54 /mo |
| Epinephrine 0.15 Pediatrics Epinephrine Pediatrics • RxCUI 1870225 | alpha-Adrenergic Agonist | 85% | $127.8321 | $ 185.00 /mo |
| Zerviate (Cetirizine) Zerviate • RxCUI 1014678-B82667015 | Histamine-1 Receptor Antagonist | 74% | $7.3243 | $ 535.85 /mo |
| Promethazine Hydrochloride Promethegan, Phenergan • RxCUI 992447 | Phenothiazine | 91% | $1.7321 | $ 5.71 /mo |
| Alcaftadine Lastacaft • RxCUI 1000085 | Histamine-1 Receptor Antagonist | 89% | $2.8333 | $ 123.25 /mo |
| Dexamethasone Maxidex, Taperdex 6-Day • RxCUI 197582 | Corticosteroid | 82% | $0.1477 | $ 5.94 /mo |
| Triamcinolone Acetonide Kenalog-40, Nasal Allergy • RxCUI 1085754 | Corticosteroid | 77% | $0.7297 | $ 6.20 /mo |
| Diphenhydramine Hydrochloride Allergy Childrens Allergy, Axiv - Vrozzz • RxCUI 1049906 | Histamine-1 Receptor Antagonist | 80% | $0.0159 | $ 5.27 /mo |
| Clemastine Fumarate Clemsza • RxCUI 857461 | FDA Prescription Therapeutic Agent | 77% | $3.1775 | $ 137.19 /mo |
| Promethegan (Promethazine Hydrochloride) Promethegan • RxCUI 992441 | Phenothiazine | 86% | $1.8404 | $ 40.39 /mo |
| Carbinoxamine Maleate Karbinal ER, Karbinal • RxCUI 1795581 | Histamine-1 Receptor Antagonist | 88% | $1.1896 | $ 14.77 /mo |
| Cetirizine Hydrochloride Allergy Relief, Allergy • RxCUI 1014673 | Histamine-1 Receptor Antagonist | 76% | $0.0210 | $ 5.45 /mo |
| Cyproheptadine Hydrochloride Periactin • RxCUI 866144 | Allergies Agent | 74% | $0.0644 | $ 5.69 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hay fever (allergic rhinitis))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Immunogenicity and safety of concomitant and sequential administration of yellow: What a 900-Participant Study Found In this study, YF-17D vaccine and TAK-003 were immunogenic and well tolerated when sequentially or concomitantly administered. PLoS neglected tropical diseases • 2023-03-15 • Phase III Randomized Trial | N = 900 | 93/100 | PMID 36888687 ↗ |
| Can This Approach Help? Inside the Latest Research on Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live No important safety risks were identified, and TAK-003 was well tolerated irrespective of age, gender, or baseline dengue serostatus in recipients aged 4-60 years. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2023-02-08 • Phase III Randomized Trial | N = 14 | 88/100 | PMID 35639602 ↗ |
| Can This Approach Help? Inside the Latest Research on A randomised, gold-standard blind, compared against a dummy pill (placebo) phase Although a primary endpoint was not met in the preceding trial, long-term administration of TCZ showed stable real-world benefits and safety for patients with crFMF. Clinical and experimental rheumatology • 2022-09-15 • Phase III Randomized Trial | N = 23 | 88/100 | PMID 36106542 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Hay fever (allergic rhinitis) Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Hay fever (allergic rhinitis) community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Hay fever (allergic rhinitis).